Fulcrum Therapeutics, Inc. (FULC) › Capital ExpendituresFulcrum Therapeutics, Inc. (FULC) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $8.98M2019: $853.0K2020: $1.34M2021: $1.71M2022: $1.96M2023: $508.0K2024: $278.0K2025: $314.0K$314.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$314.0K+12.9%2024$278.0K-45.3%2023$508.0K-74.1%2022$1.96M+14.6%2021$1.71M+27.6%2020$1.34M+57.3%2019$853.0K-90.5%2018$8.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share